Small Business Innovation Research · Small Business Technology Transfer
Zenobia Therapeutics, Inc.: SBIR & STTR awards
2 awards worth $1.23M to 1 companies since 2019 match these filters. Phase I tests an idea (usually a few hundred thousand dollars); Phase II builds it (often $1M or more).
Zenobia Therapeutics, Inc.'s federal contracts and grants · All SBIR & STTR awards
Awards by year
| Year | Phase I | Phase II | Amount |
|---|---|---|---|
| 2023 | 0 | 1 | $1.00M |
| 2019 | 1 | 0 | $225.0K |
The latest year fills in over months: agencies report awards to SBIR.gov with a lag.
Latest matching awards
| Award | Company | Agency | Phase | Amount | Date |
|---|---|---|---|---|---|
| SBIR Phase II: A web-application that enables hands-on biotech laboratory education for students regardless of socioeconomic status · topic LC | Zenobia Therapeutics, Inc. · California | National Science Foundation | SBIR Phase II | $1.00M | 2023-01-15 |
| SBIR Phase I: XplorStem(TM): A smartphone/tablet application that enables hands-on biotech laboratory education for all students regardless of socioeconomic status · topic EA | Zenobia Therapeutics, Inc. · California | National Science Foundation | SBIR Phase I | $225.0K | 2019-07-01 |
Source: SBIR.gov award data (SBA) ↗, awards through 2026-08-28. Amounts are as agencies report them to SBA. SBIR/STTR contracts also appear in USAspending as ordinary awards; grants (NIH, NSF, DOE) appear as assistance. Open topics are posted by each agency; see Opportunities for contract notices.